Role of yoga as an adjunctive therapy in patients with neurocardiogenic syncope: a pilot study

被引:11
|
作者
Gunda, Sampath [1 ]
Kanmanthareddy, Arun [2 ]
Atkins, Donita [1 ]
Bommana, Sudharani [1 ]
Pimentel, Rhea [1 ]
Drisko, Jeanne [3 ]
Dibiase, Luigi [4 ]
Beheiry, Salwa [5 ]
Hao, Steven [5 ]
Natale, Andrea [6 ]
Lakkireddy, Dhanunjaya [1 ]
机构
[1] Univ Kansas Hosp & Med Ctr, Div Cardiol, Kansas City, KS 66160 USA
[2] Creighton Univ, Div Cardiol, Omaha, NE 68178 USA
[3] Univ Kansas Hosp & Med Ctr, Div Integrat Med, Kansas City, KS USA
[4] Montefiore Med Ctr, Bronx, NY 10467 USA
[5] Calif Pacific Med Ctr, San Francisco, CA USA
[6] Texas Cardiac Arrhythmia Med Ctr, Austin, TX USA
关键词
Neurocardiogenic syncope; Yoga; Tilt study; QUALITY-OF-LIFE; NEURALLY-MEDIATED SYNCOPE; VASOVAGAL SYNCOPE; PRIMARY-CARE; DOUBLE-BLIND; MIDODRINE; FLUDROCORTISONE; EXERCISE; PRESSURE;
D O I
10.1007/s10840-015-9996-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neurocardiogenic syncope (NCS) is a common clinical condition characterized by abrupt cardiovascular autonomic changes resulting in syncope. This is a recurring condition with mixed results from current strategies of treatment. Subjects with a diagnosis of NCS were screened and enrolled. All the participants were given a DVD containing yoga videos and were instructed to practice yoga therapy for 60 min, three times a week for 3 consecutive months. Syncope functional status questionnaire score (SFSQS) was administered at the beginning and the end of the study. The subjects were followed for 3 months and underwent repeat tilt table testing at the end of the study. Of the 60 patients screened, 44 subjects were enrolled, 21 in the intervention group and 23 in the control group. Most of the participants were females, and the mean age was 21 +/- 3 years. In the intervention group, who finished the yoga regimen, there was a statistically significant improvement from control phase to the intervention phase, in number of episodes of syncope (4 +/- 1 vs 1.3 +/- 0.7, p < 0.001) and presyncope (4.7 +/- 1.5 vs 1.5 +/- 0.5, p < 0.001). The mean SFSQS also decreased from 67 +/- 7.8 to 29.8 +/- 4.6 (p < 0.001). All subjects had positive head up tilt table (HUTT) study at the time of enrollment compared to only six patients at the completion of intervention phase (10/100 vs 6/28 %, p < 0.0001). Yoga therapy can potentially improve the symptoms of presyncope and syncope in young female patients with NCS.
引用
下载
收藏
页码:105 / 110
页数:6
相关论文
共 50 条
  • [1] Role of yoga as an adjunctive therapy in patients with neurocardiogenic syncope: a pilot study
    Sampath Gunda
    Arun Kanmanthareddy
    Donita Atkins
    Sudharani Bommana
    Rhea Pimentel
    Jeanne Drisko
    Luigi Dibiase
    Salwa Beheiry
    Steven Hao
    Andrea Natale
    Dhanunjaya Lakkireddy
    Journal of Interventional Cardiac Electrophysiology, 2015, 43 : 105 - 110
  • [2] Biofeedback-Assisted Relaxation Therapy in Neurocardiogenic Syncope: A Pilot Study
    Angele V. McGrady
    Cheryl Kern-Buell
    Ellen Bush
    Rosalie Devonshire
    Alice L. Claggett
    Blair P. Grubb
    Applied Psychophysiology and Biofeedback, 2003, 28 : 183 - 192
  • [3] Biofeedback-assisted relaxation therapy in neurocardiogenic syncope: A pilot study
    McGrady, AV
    Kern-Buell, C
    Bush, E
    Devonshire, R
    Claggett, AL
    Grubb, BP
    APPLIED PSYCHOPHYSIOLOGY AND BIOFEEDBACK, 2003, 28 (03) : 183 - 192
  • [4] Cognitive behavioural therapy as a potential treatment for vasovagal/neurocardiogenic syncope - a pilot study
    Newton, JL
    Kenny, RA
    Baker, CR
    EUROPACE, 2003, 5 (03): : 299 - 301
  • [5] Is there a criterion for therapy interruption in patients with neurocardiogenic syncope?
    Hachul, D
    Bastos, S
    Ludovice, AC
    Scanavacca, M
    Sosa, E
    EUROPEAN HEART JOURNAL, 2000, 21 : 563 - 563
  • [6] Yoga Therapy as an Adjunctive Treatment for Schizophrenia: A Randomized, Controlled Pilot Study
    Visceglia, Elizabeth
    Lewis, Stephen
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2011, 17 (07) : 601 - 607
  • [7] Meta-analysis of Pacemaker Therapy in Patients With Neurocardiogenic Syncope
    Kheiri, Babikir
    Abdelazeem, Basel
    Osman, Mohammed
    Dalouk, Khidir
    Stecker, Eric
    Raitt, Merritt H.
    Henrikson, Charles A.
    Nazer, Babak
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 149 : 159 - 160
  • [8] Midodrine: a role in the management of neurocardiogenic syncope
    Ward, CR
    Gray, JC
    Gilroy, JJ
    Kenny, RA
    HEART, 1998, 79 (01) : 45 - 49
  • [9] Neurocardiogenic syncope: Response to hormonal therapy
    Boehm, KE
    Kip, KT
    Grubb, BP
    Kosinski, DJ
    PEDIATRICS, 1997, 99 (04) : 623 - 625
  • [10] NEUROCARDIOGENIC SYNCOPE - PATHOPHYSIOLOGY, DIAGNOSIS, THERAPY
    KLINGENHEBEN, T
    HOHNLOSER, SH
    ZEITSCHRIFT FUR KARDIOLOGIE, 1995, 84 (02): : 137 - 145